Idaho Strategic Resources, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Idaho Strategic Resources, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	0.54	4.28	3.63	5.67	5.67	7.63	9.58	13.7	25.8	42.4
Cost of revenue			4.36	5.38	5.61	7.14	8.03	9.69	12.8	16.2
Gross profit	0.07	1.19	-0.73	0.74	0.07	0.49	1.55	3.97	13	26.2
General and administrative	0.22	0.26	0.39	0.45	0.4	1.32	1.23	0.63	0.76	1.09
Operating expenses	1.57	0.89	-1.55	1.42	1.06	3.55	4.11	2.95	4.52	10.6
Operating income	-1.04	0.3	0.82	-0.69	-1	-3.06	-2.55	1.01	8.43	15.6
Interest expense	0.08	0.07	0.08	0.08		0.05	0.1	0.04	0.08	0
Interest income	-0.01	-0.01	-0.03	0.03	0	0	0.01	0.09	0	0.05
Other non-operating income	0.33		0.07	-0.04	0.26	-0.2	0.08	-0.06	0.33	1.46
Pre-tax income						-0			8.75	17.1
Income tax	0	0	0	0	0	0	0	0	0	0.43
Income from continuing operations		0.3	0.82
Net income to minority interests	0.02	-0.06	-0.08		-0.64	-3.16
Net income	-1.36	-0.02	0.75	-0.73	-0.74	-3.26	-2.63	1.16	8.84	16.7
EBITDA	-1.01	0.45	1.19	-0.11	-0.42	-2.25	-1.57	2.48	10.4	17.9
EPS, basic	0.01	0.00	0.00					0.09	0.68	1.15
EPS, diluted	0.01	0.00	0.00					0.09	0.67	1.14
Shares, basic (weighted)	95	107	120	124	9.2	10.2	11.8	12.3	13	14.5
Shares, diluted (weighted)	95	108	122	124	129	10.2	11.8	12.3	13.2	14.7

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	0.15	0.12	0.25	0.22	2.54	1.98	1.64	2.29	1.11	9.89
Short-term investments										3.96
Inventory	0.18	0.25	0.18	0.23	0.4	0.21	0.62	0.88	0.9	0.97
Other current assets	0.08	0.1	0	0.16	0.22	0.33	0.19	0.24	0.38	0.8
Total current assets	0.53	0.78	0.76	0.91	3.44	2.94	3.36	4.45	11.7	51.3
Property, plant and equipment	5.79	5.89	6.57	7.02	7.23	8.26	9.92	10.2	12.9	19.5
Long-term investments										0.35
Other non-current assets										0.36
Total assets	8.86	9.38	10.6	10.9	14.7	17.9	21	23.9	44	116
Accounts payable			0.4	0.53	0.69	0.65	0.58	0.48	1.01	1.9
Accrued liabilities			0.06	0.08	0.14	0.17	0.18	0.27	0.56	0.41
Total current liabilities	2.32	1.28	0.73	0.95	1.21	1.5	1.63	1.73	2.28	3.68
Long-term debt	0.27	0.18	0.42	0.9	0.71	0.96	1.32	1.34	1.02	1.3
Total liabilities	3.71	2.53	1.49	2.2	3.4	4.86	3.27	3.35	3.61	5.4
Total debt	0.89	0.27			0.71	1.63	2.17	2.32	1.73	2.33
Retained earnings	-12.3	-12.3	-11.4	-12	-12.7	-15.8	-18.4	-17.2	-8.37	8.34
Shareholders' equity	2	3.74	6.07	5.65	8.31	10.2	14.9	17.8	37.7	108
Minority interests			3.07	3	2.95	2.89	2.84	2.78	2.73	2.67
Total equity	5.15	6.85	9.15	8.66	11.3	13.1	17.7	20.5	40.4	111
Total liabilities and equity	8.86	9.38	10.6	10.9	14.7	17.9	21	23.9	44	116
Shares outstanding	97.2	112	123	124	9.83	10.9	12.1	12.4	13.7	15.7

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-1.36	-0.02	0.75	-0.73	0.74	3.26	-2.63	1.07	8.75	16.6
Depreciation and amortization	0.03	0.16	0.37	0.58	0.58	0.81	0.98	1.47	1.95	2.34
Stock-based compensation	0.29	0.14	0.04	0.19	0	1.09	0.55	0	0	1.51
Deferred income tax									0	0.09
Change in receivables	-0.01					-0.14	-0.5	-0.13	-0.54	-2.33
Change in inventory	0.18	0.06	-0.04	0.04	-0.18	0.19	-0.4	-0.26	-0.02	-0.07
Change in payables	0.18	0.12	0.04	0.13	0.16	-0.03	-0.06	-0.1	0.52	0.9
Cash from operations	-0.67	0.34	-1.42	0.21	-0.48	-1.35	-1.82	2.1	10.8	19.1
Capital expenditures	0.13	0.14	0.32			-0.66	-1.44	-0.77	-2.22	-6.71
Cash from investing	-0.45	-0.18	2.15	0.08	-1.59	-3.09	-2.37	-2.1	-20.8	-61.5
Debt issued				0	1.09	1.75
Stock issued	0.02		1.21	0	2.91	2.58	3.68	1.72	9.12	52
Share buybacks							0	-0.01
Cash from financing	1.21	-0.19	-0.61	-0.32	4.4	3.88	3.85	0.65	8.74	51.1
Net change in cash	0.09	-0.03	0.12	-0.03	2.32	-0.56	-0.34	0.65	-1.18	8.78
Free cash flow	-0.54	0.48	-1.1			-2.02	-3.26	1.33	8.62	12.4
Interest paid	0.08	0.06	0.09	0.08	0.15	0.2	0.1	0.04

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $30.39 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	64.1%	Gross profit / revenue.
Operating margin	45.1%	Operating income / revenue.
EBITDA margin	50.6%	EBITDA (operating income + depreciation and amortization) / revenue.
Net margin	44.0%	Net income / revenue.
FCF margin	33.0%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	52.7%	Cash from operations / revenue.
Return on equity (ROE)	18.6%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	17.2%	Net income / average total assets.
Return on invested capital (ROIC)	15.8%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	1.6%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	19.7%	Capital expenditures / revenue.
D&A / revenue	5.5%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	64.6%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	64.2%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	49.5%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	102.4%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	156.4%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	229.4%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	85.2%	Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y	72.8%	EBITDA vs the same period a year earlier. Only from a positive base.
Net income growth, 1y	89.2%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	70.1%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	76.2%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y	43.7%	Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y	187.0%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	93.7%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	67.1%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	164.0%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	76.9%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	51.3%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	11.4%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	7.7%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-35.2%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	12.2x	Current assets / current liabilities.
Quick ratio	2.20x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	2.20x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.02x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	1.6%	Total debt / total assets.
Liabilities / assets	5.3%	Total liabilities / total assets.
Net debt	-$6.1M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	-0.24x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Working capital	$41.8M	Current assets - current liabilities.
Tangible book value	$120.5M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.39x	Revenue / average total assets.
Fixed asset turnover	2.02x	Revenue / average property, plant and equipment.
Inventory turnover	9.64x	Cost of revenue / average inventory.
Days inventory	38 days	365 x average inventory / cost of revenue.
Days payables	46 days	365 x average accounts payable / cost of revenue.
FCF conversion	75.0%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	37.4%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$1.40	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$3.18	Revenue / diluted weighted shares.
FCF per share	$1.05	Free cash flow / diluted weighted shares.
Operating cash flow per share	$1.68	Cash from operations / diluted weighted shares.
Book value per share	$7.62	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$7.62	Tangible book value / shares outstanding.
Cash per share	$0.52	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$481.0M	Share price x shares outstanding.
Enterprise value	$474.8M	Market cap + total debt - cash - short-term investments.
P/E	21.5x	Market cap / net income. Only when net income is positive.
P/S	9.46x	Market cap / revenue.
P/B	3.99x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	3.99x	Market cap / tangible book value, when positive.
P/FCF	28.6x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	17.9x	Market cap / cash from operations, when positive.
EV/Sales	9.34x	Enterprise value / revenue.
EV/EBIT	20.7x	Enterprise value / operating income, when both are positive.
EV/EBITDA	18.5x	Enterprise value / EBITDA, when both are positive.
EV/FCF	28.3x	Enterprise value / free cash flow, when both are positive.
FCF yield	3.5%	Free cash flow / market cap.
Earnings yield	4.7%	Net income / market cap (the inverse of P/E).

What was Idaho Strategic Resources, Inc.'s revenue in fiscal 2025?

Idaho Strategic Resources, Inc. reported revenue of $42.4M for fiscal 2025, 64.6% higher than the year before.

Was Idaho Strategic Resources, Inc. profitable in fiscal 2025?

Yes. Net income was $16.7M, a net margin of 39.4%.

How much free cash flow did Idaho Strategic Resources, Inc. generate in fiscal 2025?

Cash from operations of $19.1M minus capital expenditures of $6.7M left free cash flow of $12.4M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Idaho Strategic Resources, Inc.